Alkermes Share Price

Alkermes Share Price

NASDAQ: ALKS | Mid Cap | Healthcare
$46.42
+$0.97 (2.12%) Last updated on 19 Nov, 2026 | 01:25 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • Similar Stocks
  • FAQs

Alkermes Stock Performance

Open
$45.88
Prev. Close
$45.45
Circuit Range
N/A
Day Range
$45.88 - $47.05
Year Range
$27.00 - $55.60
Volume
32,581
Average Traded
$46.51

Alkermes Share Price Today

As of 19 November 2026, Alkermes plc's share price is $46.42. The stock opened at $45.88, compared to its previous close of $45.45. During today's trading session, Alkermes plc's share price traded between $45.88 and $47.05, with an average price of $46.46. Over the past 52 weeks, the stock has recorded a high of $55.60 and a low of $27.00. In terms of performance, Alkermes plc's share price has risen by 10.04% over the last six months and is up 57.04% on a year-on-year basis.

Alkermes Share Price Chart

Line chart of the Alkermes price trend over the selected period. The price rose overall, ranging from 45.43 to 47.05, ending at 46.42.
$45.88$47.05
L
Show Current Price
H

Alkermes Stock Fundamentals & Key Indicators

Market Cap
$7.65B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$0.00
Revenue (TTM)
$1.48T
Return On Equity (TTM)
-0.02%
Profit Margin
16.37%
Debt to Equity
0.80
Quarterly Earnings Growth YoY
-66.98%

Alkermes Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$384.55$392.91$496.01$480.13
Net Profit$49.34-$66.48$0.50$16.29
Net Profit Margin12.83%-16.92%0.10%3.39%
Income ChangeN/A-234.74%100.75%3158.00%

Alkermes Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$1111.80$1663.41$1557.63$1475.90
Net Profit-$158.27$355.76$367.07$241.66
Net Profit Margin-14.24%21.39%23.57%16.37%
Income ChangeN/A324.78%3.18%-34.17%

Alkermes Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets557.83640.21650.72833.67
Current Assets1929.161415.361485.511130.31
Total Assets2486.992055.572136.221963.98
Non Current Liabilities124.26125.39417.86414.79
Current Liabilities543.44465.2515.68505.44
Total Liabilities667.7590.59933.54920.23
Shareholders' Equity1819.31464.981202.691043.75

Alkermes Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating520.75439.12401.3521.04
Investing295.5-111.3153.36-64.54
Financing12.38-494.14-289.71-1.57

About Alkermes

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Alkermes Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$45.52
$46.39
+2.35%
Oct 2026
$40.58
$45.33
+11.71%
Sep 2026
$47.22
$40.58
-16.99%
Aug 2026
$49.08
$48.88
-0.20%
Jul 2026
$52.27
$48.98
-6.51%
Jun 2026
$42.09
$52.39
+24.19%
May 2026
$33.22
$42.19
+25.10%
Apr 2026
$35.81
$33.72
-4.69%
Mar 2026
$29.69
$35.38
+17.62%
Feb 2026
$33.52
$30.08
-11.22%
Jan 2026
$28.16
$33.88
+21.13%
Dec 2025
$29.25
$27.97
-5.38%

Alkermes Share Price FAQs